School of Medicine, Stanford University, Stanford, CA, USA.
Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
J Med Econ. 2024 Jan-Dec;27(1):1027-1035. doi: 10.1080/13696998.2024.2386819. Epub 2024 Aug 12.
Food allergies impose a large clinical and financial burden on patients and the health care system. However, little is known about the factors associated with health care resource use and costs. The aim of this study was to investigate health care resource use and costs in individuals with food allergies utilizing health care in the United States.
We conducted a retrospective analysis of insurance claims data from the Merative MarketScan Research Databases (indexed from 1 January 2015 to 30 June 2022). All-cause and food allergy-related health care resource use, direct medical, and out-of-pocket costs for medical services were estimated for 12 months post-index using codes.
Of 355,520 individuals with food allergies continuously enrolled in a health insurance plan for ≥12 months pre- and post-index, 17% had a food allergy-related emergency department visit and 0.9% were hospitalized. The top patient characteristic associated with all-cause and food allergy-related hospitalizations, all-cause costs, and food allergy-related outpatient visit costs was a Charlson Comorbidity Index score of ≥2. Food allergy-related direct medical and out-of-pocket costs were high among patients with a food allergy-related visit. Out-of-pocket cost per patient per year for outpatient visits, emergency department visits, and hospitalizations had an estimated mean of $1631 for patients with food allergy-related visits, which is ∼11% of the total costs for these services ($14,395 per patient per year).
Study limitations are primarily related to the nature of claims databases, including generalizability and reliance on codes. Nevertheless, MarketScan databases provide robust patient-level insights into health care resource use and costs from a large, commercially insured patient population.
The health care resource use of patients with food allergies imposes a burden on both the health care system and on patients and their families, especially if patients had comorbidities.
食物过敏给患者和医疗保健系统带来了巨大的临床和经济负担。然而,人们对与医疗保健资源利用和成本相关的因素知之甚少。本研究旨在调查美国食物过敏患者的医疗保健资源利用和成本。
我们对 Merative MarketScan 研究数据库(从 2015 年 1 月 1 日至 2022 年 6 月 30 日索引)的保险索赔数据进行了回顾性分析。使用 代码估计索引后 12 个月内的全因和食物过敏相关医疗保健资源利用、直接医疗和自付医疗费用。
在索引前和索引后连续参加医疗保险计划≥12 个月的 355520 名食物过敏患者中,有 17%有食物过敏相关急诊就诊,0.9%住院。与全因和食物过敏相关住院、全因费用和食物过敏相关门诊就诊费用相关的主要患者特征是Charlson 合并症指数评分≥2。有食物过敏相关就诊的患者中,食物过敏相关直接医疗和自付费用较高。有食物过敏相关就诊的患者,门诊就诊、急诊就诊和住院的自付费用人均每年估计为 1631 美元,占这些服务总费用的 11%(每位患者每年 14395 美元)。
研究的局限性主要与索赔数据库的性质有关,包括普遍性和对 代码的依赖。然而,MarketScan 数据库从大型商业保险患者群体中提供了关于医疗保健资源利用和成本的强大的患者水平见解。
食物过敏患者的医疗保健资源利用给医疗保健系统以及患者及其家属带来了负担,特别是如果患者有合并症的话。